Advertisement

Topics

Global Coronary Artery Disease Therapeutics Market 20172021 [Report Updated: 31102017] Prices from USD $3500

07:01 EST 13 Nov 2017 | BioPortfolio Report Blog

About Coronary Artery Disease Therapeutics


Coronary artery disease CAD is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries that prevents the supply of an adequate amount of blood supply to the heart. It happens when a coronary artery gets hardened or narrowed due to various reasons such as the buildup of cholesterol or other materials known as plaque on the inner wall of the artery. This buildup is known as atherosclerosis. With passing time, a lesser amount of blood flows through the arteries. As a result heart muscle fails to get the required amount of blood or oxygen.


Technavio's analysts forecast the global coronary artery disease therapeutics market to grow at a CAGR of 5.17% during the period 20172021.


Covered in this report

The report covers the present scenario and the growth prospects of the global coronary artery disease therapeutics market for 20172021. To calculate the market size, the report considers the sales of branded, generic, and offlabel drugs.


The market is divided into the following segments based on geography:

Americas

APAC

EMEA


Technavio's report, Global Coronary Artery Disease Therapeutics Market 20172021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors

AstraZeneca

Gilead

Novartis

Pfizer

Other prominent vendors

Bayer,

BristolMyers Squibb,

GlaxoSmithKline,

Merck,

Mylan,

Teva Pharmaceutical Industries

Market driver

Growing geriatric population

For a full, detailed list, view our report


Market challenge

Highly genericized market

For a full, detailed list, view our report


Market trend

Growing strategic alliances

For a full, detailed list, view our report


Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?


You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Coronary Artery Disease Therapeutics Market 20172021 [Report Updated: 31102017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global Coronary Artery Disease Therapeutics Market 20172021 [Report Updated: 31102017] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...